Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.
In the U.S., Lundbeck employs more than 800 people focused solely on accelerating therapies for brain disorders. With a special commitment to the lives of patients, families and caregivers, Lundbeck U.S. actively engages in hundreds of initiatives each year that support our patient communities.
Six Parkway North
Deerfield, IL 60015
+1 (847) 282-1000
Parkinson’s disease can’t be slowed or cured, but researchers like Dr. Williamson are working to cha…READ MORE
Thanks to Parkinson’s Disease research and treatment advances, astronaut Rich Clifford continues to…READ MORE
Biopharma researchers like Doug are fighting to give Parkinson's patients like Rich their normal liv…READ MORE
The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.READ MORE
America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.READ MORE
Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?READ MORE
September is Blood Cancer Awareness Month, which aims to raise awareness for patients with one of several types of blood cancer, including leukemia, lymphoma and myeloma.READ MORE